Wei Wu

Dr. Wei Wu


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2021 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
SZShumin Zhan
Shumin Zhan
KHKe Huang
Ke Huang
WWWei Wu
Wei Wu
DZDanni Zhang
Danni Zhang
ALAna Liu
Ana Liu
JFJunfen Fu
Junfen Fu
Context: Although gonadotropin-releasing hormone stimulation test (GnRHST) is the gold standard in diagnosing central precocious puberty (CPP), it is invasive, expensive, and time-consuming, requiring multiple blood samples to measure gonadotropin levels.Objective: We evaluated whether urinary hormones could be potential biomarkers for prepuberty or postpuberty, aiming to simplify the current diagnosis and prognosis procedure.Methods: We performed a cross-sectional study of a total of 355 girls with CPP in National Clinical Research Center for Child Health in China, including 258 girls with positive and 97 girls with negative results from GnRHST. Twenty patients received GnRH analogue (GnRHa) treatment and completed a 6-month follow up. We measured luteinizing hormone (LH), follicle-stimulating hormone (FSH), estradiol, prolactin, progesterone, testosterone, and human chorionic gonadotropin in the first morning voided urine samples.Results: Their urinary LH levels and the ratios of LH to FSH increased significantly with the advancement in Tanner stages. uLH levels were positively associated with basal and peak LH levels in the serum after GnRH stimulation. A cutoff value of 1.74 IU/L for uLH reached a sensitivity of 69.4% and a specificity of 75.3% in predicting a positive GnRHST result. For the combined threshold (uLH ≥ 1.74 + uLH-to-uFSH ratio > 0.4), the specificity reached 86.6%. After 3 months of GnRHa therapy, the uLH and uFSH levels decreased accordingly.Conclusion: uLH could be a reliable biomarker for initial CPP diagnosis and screening; uLH could also be an effective marker for evaluating the efficacy of clinical treatment.

12 November 2024 in Journal of Endocrinological Investigation
Verified
Journal Article
Closed access
PDF file
YSYingxiao Shen
Yingxiao Shen
WYWei Yang
Wei Yang
QHQin He
Qin He
XXXiaoqin Xu
Xiaoqin Xu
YSYan Sun
Yan Sun
JFJunfen Fu
Junfen Fu

17 June 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
XZXuelian Zhou
Xuelian Zhou
XCXuefeng Chen
Xuefeng Chen
LZLi Zhang
Li Zhang
JYJinna Yuan
Jinna Yuan
HLHu Lin
Hu Lin
WWWei Wu
Wei Wu
Objective: To investigate the role of mannose-binding lectin (MBL) in modulating autophagy and protecting endothelial cells (ECs) from oxidized low-density lipoprotein (ox-LDL)-induced injury. Methods: Serum MBL concentration and carotid intima-media thickness (cIMT) were measured in 94 obese and 105 healthy children. ECs were transfected with MBL over-expression plasmid, LOX1 was knocked-down to explore the protective role of MBL in ox-LDL induced ECs injury. Dendritic cells (DCs) were co-cultured with ECs, and inflammatory factors, DC maturation, and autophagy was assessed. WT and ApoE−/− mice were fed with a high fat diet (HFD) with or without MBL-adenovirus injection for 16 weeks and aortic vascular endothelial tissue was isolated, then atherosclerotic plaque, cell injury and autophagy were analyzed. Results: Serum MBL concentration in obese children was lower than healthy controls and was negatively correlated with cIMT. The uptake of ox-LDL was decreased in LOX1 knock-down ECs. MBL over-expression in vitro inhibited LOX1-ox-LDL binding. Both LOX1 knock-down and MBL over-expression can ameliorate EC autophagy and cell injury. MBL over-expression in vivo alleviated atherosclerotic plaque formation, influenced DC maturation and down-regulated IL-6, IL-12, and TNF-a levels. Conclusions: MBL exerts a protective role in ox-LDL-induced EC injury by modulating DC maturation and EC autophagy via inhibiting LOX1-ox-LDL binding.

14 February 2025 in Acta Paediatrica
Verified
Journal Article
Open access
SZShumin Zhan
Shumin Zhan
QHQin He
Qin He
JYJinna Yuan
Jinna Yuan
XXXiaoqin Xu
Xiaoqin Xu
KHKe Huang
Ke Huang
WWWei Wu
Wei Wu
Aim: Type II collagen, encoded by the collagen type II alpha 1 (COL2A1) gene, is crucial for the structure of cartilage. This study aims to improve our understanding of Spondyloepiphyseal Dysplasia Congenita (SEDC) caused by mutations in COL2A1. We also aim to evaluate the safety and efficacy of growth hormone (GH) therapy in two SEDC patients.Methods: We performed genetic analyses of seven paediatric patients from unrelated Chinese families. Two patients received GH therapy, and their growth trajectories were monitored over 3.5 and 3 years.Results: Genetic screening identified six missense mutations (Gly1110Ser, Gly1107Glu, Gly873Arg, Gly456Ala, Gly1062Ser and Gly1182Arg) and one intron variant in COL2A1. All patients (five girls and two boys, ranging from 2 years and 7 months to 12 years) were diagnosed with SEDC, exhibiting disproportionate short stature and skeletal abnormalities. GH therapy resulted in height increases of 0.76 and 0.27 standard deviation scores over 3.5 and 3 years, respectively, with no significant side effects.Conclusion: This study expands the mutation spectrum of COL2A1 and supports the efficacy and safety of GH therapy in SEDC patients, highlighting the need for multi‐center studies to further investigate GH's therapeutic potential.

22 February 2024 in World Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
ZWZhao-Yuan Wu
Zhao-Yuan Wu
SCSi-Wei Chi
Si-Wei Chi
LOLiu-Jian Ouyang
Liu-Jian Ouyang
XXXiao-Qin Xu
Xiao-Qin Xu
JCJing-Nan Chen
Jing-Nan Chen
WWWei Wu
Wei Wu

9 February 2019 in Clinical Endocrinology
Verified
Journal Article
Closed access
PDF file
YHYe Hong
Ye Hong
SMSarah Maessen
Sarah Maessen
GDGuanping Dong
Guanping Dong
KHKe Huang
Ke Huang
WWWei Wu
Wei Wu
JFJunFen Fu
JunFen Fu